Shared Mechanisms of GABAergic and Opioidergic Transmission Regulate Corticolimbic Reward Systems and Cognitive Aspects of Motivational Behaviors
Affiliations
The functional interplay between the corticolimbic GABAergic and opioidergic systems plays a crucial role in regulating the reward system and cognitive aspects of motivational behaviors leading to the development of addictive behaviors and disorders. This review provides a summary of the shared mechanisms of GABAergic and opioidergic transmission, which modulate the activity of dopaminergic neurons located in the ventral tegmental area (VTA), the central hub of the reward mechanisms. This review comprehensively covers the neuroanatomical and neurobiological aspects of corticolimbic inhibitory neurons that express opioid receptors, which act as modulators of corticolimbic GABAergic transmission. The presence of opioid and GABA receptors on the same neurons allows for the modulation of the activity of dopaminergic neurons in the ventral tegmental area, which plays a key role in the reward mechanisms of the brain. This colocalization of receptors and their immunochemical markers can provide a comprehensive understanding for clinicians and researchers, revealing the neuronal circuits that contribute to the reward system. Moreover, this review highlights the importance of GABAergic transmission-induced neuroplasticity under the modulation of opioid receptors. It discusses their interactive role in reinforcement learning, network oscillation, aversive behaviors, and local feedback or feedforward inhibitions in reward mechanisms. Understanding the shared mechanisms of these systems may lead to the development of new therapeutic approaches for addiction, reward-related disorders, and drug-induced cognitive impairment.
Wongveerakul P, Cheaha D, Kumarnsit E, Samerphob N Exp Brain Res. 2024; 243(1):7.
PMID: 39611892 DOI: 10.1007/s00221-024-06968-8.
Gut Microbiome-Mediated Mechanisms in Alleviating Opioid Addiction with Aqueous Extract of .
Baslam A, Kabdy H, Chait Y, Azraida H, El Yazouli L, Aboufatima R Biomedicines. 2024; 12(6).
PMID: 38927359 PMC: 11200529. DOI: 10.3390/biomedicines12061152.
Analgesic Peptides: From Natural Diversity to Rational Design.
Gach-Janczak K, Biernat M, Kuczer M, Adamska-Bartlomiejczyk A, Kluczyk A Molecules. 2024; 29(7).
PMID: 38611824 PMC: 11013236. DOI: 10.3390/molecules29071544.
GABA system as the cause and effect in early development.
Topchiy I, Mohbat J, Folorunso O, Wang Z, Lazcano-Etchebarne C, Engin E Neurosci Biobehav Rev. 2024; 161:105651.
PMID: 38579901 PMC: 11081854. DOI: 10.1016/j.neubiorev.2024.105651.
Babenko V, Redina O, Smagin D, Kovalenko I, Galyamina A, Kudryavtseva N Int J Mol Sci. 2024; 25(5).
PMID: 38474132 PMC: 10931827. DOI: 10.3390/ijms25052882.